Abstract

The crystal changes and salt formation of poorly water-soluble telmisartan (TEL) in various solvents were investigated for enhanced solubility, stability and crystallinity. Polymorphic behaviors of TEL were characterized by dispersing in distilled water, acetone, acetonitrile, DMSO, or ethanol using Method I: without heat and then dried under vacuum at room temperature; and Method II: with heat below boiling temperature, cooled at 5 °C, and then dried under vacuum at 40 °C. For salt formation (Method III), the following four powdered mixtures were prepared by dispersing in solution of hydrochloric acid (HCl) (pH 1.2), TEL/HCl; in simulated gastric fluid (pH 1.2 buffer), TEL/simulated gastric fluid (SGF); in intestinal fluid (pH 6.8 buffer), TEL/simulated intestinal fluid (SIF); or in NaOH (pH 6.8), TEL/NaOH, respectively, and then dried under a vacuum at room temperature. The structures of powdered mixtures were then studied using a field emission scanning electron microscope (FESEM), differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), FTIR, 1H nuclear magnetic resonance (1H-NMR), and LC–MS. The solubility of TEL in powdered forms was performed in pH 6.8, pH 1.2, and distilled water. No polymorphic behaviors of TEL were observed in various solvents as characterized by FESEM, DSC, PXRD, and FTIR. However, the structural changes of powdered mixtures obtained from Method III were observed due to the formation of salt form. Moreover, the solubility of salt form (TEL/HCl) was highly increased as compared with pure TEL. There were no significant changes of TEL/HCl compared with TEL in the content assay, PXRD, DSC, and FTIR during stressed storage conditions at 40 °C/75% relative humidity (RH) for 4 weeks under the closed package condition. Therefore, the present study suggests the new approach for the enhanced stability and solubility of a poorly water-soluble drug via salt form.

Highlights

  • PolymorphisPmoliysmoonrepohfisthmeipsoopnuelaorf wthaeypsofpour liamrpwroayvsinfgorpihmypsircoovcihnegmpihcaylsipcroocpheermtieicsaol fpvroaprieorutises of various drugs

  • The NMR peaks of powdered mixtures obtained from the TEL/hydrochloric acid (HCl) solutionrew9ereshsolwigshttlhyes1hHif‐tNedMvRiapesaakltsfoofrmTaEtLioannodf pToEwLd. eTrheed 1mHi-xNtuMreRs odbattaainoefdthferoTmELTEaLn/dHCthle spolouwtidoenre(pdHm1i.x2t)u. rTehseosbhtaifitnoedf NfrMomR stihgenaTlsELh/asHbCelensoaluffteicotned(pbHy s1li.2g)htisdilfifsetreedncines Tinabtlhee2s.aTmhpeleδ esnivginraolnomfe7n.1ts7.~T7h.1e9N(dM,R2Hpe) adkissaopfppeoawredde,raenddm7i.x9t0u~r7es.9o4b(tda,in1eHd),fr8o.m06 t(hse, 1THE)L/aHppCelasroeldutiinonp(opwHd1er.2e)d wmeirxetuslriegshotlbytasihnieftdedfrovmia tshaelt TfoErLm/aHtiConl soofluTtiEoLn. (TphHe 11H.2‐)N

  • MThRe dcahtaangoef sthoef tThEeLseaδndsigthnealps oinwddicearetedd mmixotluecreuslaorbitnatienreadctfiroonmofththeeTiEonLi/zHeCdlcsaorlbuotxioynl g(proHup1.a2n) distlhiseteNd–Hin bToanbdleb2e.tTwheeenδ HsigCnl aalnodf t7h.e17p~a7r.t19oflbdeisnazpimpeidaraezdo,leanodf T7E.9L0[~277.9].4 (d, 1H), 8.06 (s, 1H) appeared in powdered mixtures obtained from the TEL/HCl solution

Read more

Summary

Introduction

PolymorphisPmoliysmoonrepohfisthmeipsoopnuelaorf wthaeypsofpour liamrpwroayvsinfgorpihmypsircoovcihnegmpihcaylsipcroocpheermtieicsaol fpvroaprieorutises of various drugs. Salt formatioSnalits faocrmomatmioonnilsyaucsoedmmmeotnhloydufsoerdemnheathnocdinfgopr henyshiacnoccihnegmpihcaylspicroocpheermtieicsaolfpvraorpieorutsies of various drugs, includdriunggs,soinlucbluilditiyng[3s]o. Pharmaceutics 2019, 11, 102 water-soluble drugs due to the complex process associated with stability and purity of TEL [21]. No detailed investigation about mechanism of TEL salts formation has been reported based on structural changes. The commercial product Micardis® and various researches of TEL were associated with salt formation of sodium or alkalizing agent using solid dispersion technology [19,23]. These studies still contain limited knowledge regarding crystallization and salt formation of TEL, as well as effective control of hygroscopicity without Alu/Alu packaging

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call